NCT03433378View on ClinicalTrials.gov

To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

700

Participants

Timeline

Start Date

August 4, 2017

Primary Completion Date

January 26, 2018

Study Completion Date

January 26, 2018

Conditions

Acne Vulgaris

Interventions

DRUG

Tretinoin cream, 0.05%

DRUG

RETIN-A® (tretinoin) cream, 0.05%

DRUG

Vehicle of the test product

Trial Locations (1)

28217

Catawba Research, LLC, Charlotte

All Listed Sponsors

lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT03433378 - To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter